Fundraising FoxJacobiopharma
Beijing, CN · 3 known investors
Find your way into Jacobiopharma
Sign up to see every warm intro you have to Jacobiopharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Jacobiopharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Jacobio is a biopharmaceutical company developing novel oncology therapeutics, focusing on next-generation antibody-conjugated drugs including ATDCs, ISACs, and AOCs to treat cancer patients.
Founders & leadership
WY
Wang YinxiangFounder
WY
Wang YiCo-Chief Executive Officer, Chief Medical Officer
Investors · 3
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Jacobiopharma do?
- Jacobio is a biopharmaceutical company developing novel oncology therapeutics, focusing on next-generation antibody-conjugated drugs including ATDCs, ISACs, and AOCs to treat cancer patients.
- Who founded Jacobiopharma?
- Jacobiopharma was founded by Wang Yinxiang.
- Who are Jacobiopharma's investors?
- Jacobiopharma's investors include LAV, Lilly Asia Ventures, Qiming Venture Partners.
- Where is Jacobiopharma headquartered?
- Jacobiopharma is headquartered in Beijing, CN.